EPTIS
BAM Logo

Bacterial Genome Detection - Multiplex tests - PCR/NAT for gastrointestinal pathogens (548)

[Bakteriengenom-Nachweis – PCR/NAT Multiplex Nachweisverfahren für Gastrointestinale Pathogene (548)]

EPTIS factsheet 1450745 | Last revision 2026-01-30 | URL: https://www.eptis.bam.de/pts1450745 https://www.eptis.bam.de/pts1450745

PT provider
PT provider INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
Based in Germany
Language(s) German, English
Remarks Mixtures of 0 to 4 of the different pathogens specified in the panel are to be expected in the respective individual samples: Selection of Aeromonas spp., Campylobacter spp., Clostridium difficile (toxinogen), Enterohemorrhagic E. coli (EHEC / STEC), Enterotoxigenic E. coli (ETEC), Enteropathogenic E. coli (EPEC), Enteroaggregative E. coli (EAEC), Escherichia coli O157, Plesiomonas spp., Salmonella spp., Shigella/EIEC, Vibrio spp., Yersinia enterocolitica. In order to take into account the usually very different pathogen coverage of commercially available multiplex PCR/NAT concepts, each of the parameters listed above is certified separately as part of the evaluation. Only results from multiplex PCR/NAT test systems with a precisely specified test/kit designation are accepted. The parallel use of singleplex PCR/NAT detection methods for individual pathogens in the panel is not certified. The relatively broad spectrum of pathogen-specific EQA programmes for bacterial genome detection PCR/NAT is still available for this purpose. The interdisciplinary, non-profit, scientific and medical association INSTAND e. V. is a reference institution for the quality control of medical laboratories. It is one of four German reference institutions responsible for the organization of external quality assessment (EQA) schemes for quality control in medical laboratories. You can register for EQAs, submit your results and later download your evaluation documents via https://rv-online.instandev.de. The price on our website apply exclusively to orders placed via INSTAND e.V. Prices and services may differ for orders placed via distributors. Our newest EQA program can also be found on our website: https://www.instand-ev.de/en/instand-eqas/eqa-program/
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
4 samples of 0.3 mL lyophilized cell suspension, respectively Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for simultaneous qualitative detection of up to four different gastrointestinal pathogens. -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants 100 - 250
Accredited or otherwise reviewed by a 3rd party

Accredited by DAkkS (Germany) on the basis of ISO/IEC 17043

German Bundesärztekammer (General medical Council)

Operation is commissioned / requested by German Bundesärztekammer (General medical Council)
Fees and frequency
Participation fee
Regularly operated Yes (2 times per year)
Year of first operation Experience with operation of ILCs since 1968
Contact details of the PT provider
Provider Contact person
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20
40223 Düsseldorf
Germany

Phone: +49-211-159213-0
Fax:
Web: http://www.instandev.de/ http://www.instandev.de/
Dr. rer. nat. Nathalie Weiss
Phone: +49-211-159213430
Fax:
Email: weiss@instand-ev.de weiss@instand-ev.de
If you find any mistakes please contact the responsible EPTIS coordinator in Germany, Mr Johannes van de Kreeke. Mr Johannes van de Kreeke.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5